| __timestamp | Bio-Techne Corporation | Viking Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 30945000 | 22223073 |
| Thursday, January 1, 2015 | 40853000 | 6966842 |
| Friday, January 1, 2016 | 45187000 | 9000499 |
| Sunday, January 1, 2017 | 53514000 | 13741186 |
| Monday, January 1, 2018 | 55329000 | 19040000 |
| Tuesday, January 1, 2019 | 62413000 | 23559000 |
| Wednesday, January 1, 2020 | 65192000 | 31931000 |
| Friday, January 1, 2021 | 70603000 | 44981000 |
| Saturday, January 1, 2022 | 87140000 | 54234000 |
| Sunday, January 1, 2023 | 92493000 | 63806000 |
| Monday, January 1, 2024 | 96664000 |
Unleashing insights
In the competitive landscape of biotechnology, strategic investment in research and development (R&D) is crucial for innovation and growth. Over the past decade, Bio-Techne Corporation and Viking Therapeutics, Inc. have demonstrated distinct approaches to R&D spending. Bio-Techne has consistently increased its R&D budget, with a notable 212% rise from 2014 to 2023. This commitment underscores their focus on pioneering advancements and maintaining a competitive edge. Meanwhile, Viking Therapeutics has shown a remarkable 187% increase in R&D expenses over the same period, reflecting their aggressive pursuit of novel therapeutic solutions. However, data for 2024 is missing for Viking, indicating potential shifts in strategy or reporting. As these companies continue to innovate, their R&D investments will likely play a pivotal role in shaping the future of biotechnology.
Comparing Innovation Spending: Novo Nordisk A/S and Bio-Techne Corporation
Comparing Innovation Spending: Johnson & Johnson and Bio-Techne Corporation
Analyzing R&D Budgets: Gilead Sciences, Inc. vs Bio-Techne Corporation
Analyzing R&D Budgets: Alnylam Pharmaceuticals, Inc. vs Bio-Techne Corporation
Research and Development: Comparing Key Metrics for Bio-Techne Corporation and Apellis Pharmaceuticals, Inc.
Research and Development Investment: Bio-Techne Corporation vs Rhythm Pharmaceuticals, Inc.
R&D Insights: How Bio-Techne Corporation and ADMA Biologics, Inc. Allocate Funds
R&D Insights: How Bio-Techne Corporation and Wave Life Sciences Ltd. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Viking Therapeutics, Inc.
Viking Therapeutics, Inc. or CRISPR Therapeutics AG: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Viking Therapeutics, Inc. vs HUTCHMED (China) Limited
Research and Development Expenses Breakdown: Viking Therapeutics, Inc. vs Xencor, Inc.